ChromaDex Corp. announces new patents for NAD+ precursors Nutritional Outlook, 01 Mar 2023 ChromaDex Corp. has announced a newly granted U.S. Patent 11,584,770 for purity compositions of dihydronicotinamide riboside (NRH…